Pegasys 180 MCG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FCJ9T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,801
Award facts
- Contract value 100% obligated
- $5,800.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,800.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on October 22, 2025, with completion targeted for October 23, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order procures a specific pharmaceutical product to support military healthcare operations. Pegasys is an antiviral medication used in hepatitis C treatment, and the syringes will be delivered to the company's Conshohocken, Pennsylvania facility. The prime SPE2DX contract represents a comprehensive global pharmaceutical support vehicle that enables AmerisourceBergen to supply a broad range of pharmaceutical products, generic and brand-name drugs, vaccines, and medical supplies across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This particular delivery order exemplifies the routine pharmaceutical procurement operations conducted under the larger strategic contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FCJ9T?
SPE2DR26FCJ9T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FCJ9T worth?
The government has obligated $5,801 on SPE2DR26FCJ9T.
Is contract SPE2DR26FCJ9T an order under another contract?
Yes. SPE2DR26FCJ9T is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCJ9T competed?
The extent of competition for SPE2DR26FCJ9T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award